Partial clinical hold from FDA, for use of nomlabofusp for the treatment of patients with Friedreich's Ataxia completely lifted; higher dosing of 50 mg of treatment now possible. It is expected that ...

Larimar Therapeutics LRMR is a clinical-stage company making medicines for rare diseases. The company has a Zacks Rank #1 (Strong Buy). Here we discuss some reasons why investing in LRMR stock now is ...

The Dominican Republic wants jewelers to love larimar, the national stone. But authorities shut the mine temporarily after two fatal accidents. The inspiration for Joarla Caridad’s Pool Ring with ...

It’s been well over a year since the FDA slapped a hold on Larimar Therapeutics’ only clinical asset. Now, after a meeting with the agency, the biotech is preparing to submit a full response, ...

BALA CYNWYD, Pa., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced an updated timeline for submitting its Biologics License Application (BLA) for nomlabofusp, a potential first-in-class ...

Maintaining a Hold rating on Larimar Therapeutics due to early-stage development of nomlabofusp for Friedreich's ataxia and uncertainty about its functional benefits. The stock has dropped over 50% ...

BALA CYNWYD, Pa. - Larimar Therapeutics, Inc. (NASDAQ:LRMR), currently trading at $3.53 with a market capitalization of $226 million, has priced its underwritten public offering of 18,750,000 shares ...

During the temporary closures as a result of the COVID-19 (coronavirus) pandemic, AMResorts it will further renovate Secrets Royal Beach Punta Cana and Now Larimar Punta Cana, in addition to swapping ...

See disclosure here or remove ads. The company reported that some participants in the OLE study have now been on treatment for up to 15 months at both 25 mg and 50 mg doses. The study has been ...